Staging Preclinical Alzheimer’s Disease Pathologies
COMBINED tau biomarkers track early cognitive decline and forecast structural neurodegeneration in preclinical Alzheimer’s disease. Clinicians evaluating asymptomatic individuals with confirmed amyloid-beta deposition frequently face…